Statement | 23 January 2014 Intellectual property and trade India MSF response to Bayer CEO statement that medicines developed only for western patients
Statement | 21 January 2014 Hepatitis C MSF intervention on hepatitis at WHO 134th Executive Board meeting
Statement | 20 January 2014 Intellectual property and trade South AfricaIndia MSF urges South Africa to stand strong in defiance of aggressive pharma moves to delay change 5 min
Statement | 20 January 2014 Tuberculosis MSF intervention on Global Strategy for TB at WHO 134th Executive Board meeting
Statement | 19 January 2014 Vaccines MSF intervention on the Global Vaccine Action Plan at WHO 134th Executive Board meeting
Statement | 11 December 2013 Research and development MSF responds to G-FINDER survey on R&D funding for neglected diseases
Statement | 22 November 2013 Tuberculosis MSF Responds to EMA approval of new tuberculosis drug delamanid
Statement | 13 November 2013 Intellectual property and trade MSF responds to leak of Trans-Pacific Partnership text on Wikileaks
